Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
Abroad (travel likely)Recruiting
Conditions
Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Fudan University Shanghai Cancer Center, Shanghai, China
Study leads
Xiaoyan Zhou, PhD
Principal Investigator
Fudan University